Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Orphan drug status for microplasmin in pediatric eye surgery

April 6, 2004

SnET2-PDT NDA submitted for AMD

April 5, 2004

Lupin to promote Zymar to U.S. pediatricians

April 2, 2004

ThromboGenics and NuVue collaborate on plasmin products for visual disorders

March 16, 2004

Iquix receives FDA approval for bacterial corneal ulcer

March 15, 2004

VEGF Trap enters clinical development program

March 12, 2004

Positive results from Xibrom phase III studies

March 11, 2004

Additional phase III data in support of TTFC

March 10, 2004

Alrex safe for long-term treatment of seasonal allergic conjunctivitis

Feb. 24, 2004

Senju claims new chymase and/or tryptase inhibitors and their use

Feb. 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...